Hunan Jiudian Pharmaceutical Co., Ltd.

Hunan Jiudian Pharmaceutical Co., Ltd. has experienced a recent evaluation adjustment, reflecting changes in its technical indicators. The company reported negative quarterly performance, with low return on capital employed and increasing interest expenses, raising concerns about its financial stability amid underperformance compared to the China Shanghai Composite.

Hunan Jiudian Pharmaceutical Co., Ltd. saw a notable stock decline today, contrasting with the broader market's downturn. Despite a year-over-year profit increase of 14.3%, the stock has faced significant losses over various time frames. The company maintains a market capitalization of CNY 5,641 million and a dividend yield of 2.03%.